AlphAIAlphAI — Financial news for AI agents
SEC EDGARAUG 241 min read

Bart Andrew John sold $64K of CRD-A

Bart Andrew John (Executive Vice President) sold 4,907 shares of CRAWFORD & CO (CRD-A) at an average of $13.10 ($12.96–$13.13) across 2 trades over 2026-08-20 to 2026-08-21.

Original reporting
SEC EDGAR · Bart Andrew John
Published Aug 24, 2026, 7:27 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 24, 2026, 8:15 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefInsider activity
Primary signal
MARKET
Neutral
AI market analysis
Mentioned
$CRD-A
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

Low
01

Why it matters

Insider sale of $64K by an executive; minimal market impact.

02

Market read

Routine insider transaction with limited trading relevance.

03

What to watch

Potential upcoming corporate actions not disclosed.

Relevance 3/10Novelty 3/10Timing: filed 2026-08-24

Background

SEC Form 4 filing reporting insider transaction.

Market effects

Sector

none

Regional

none

Global

none

Counterpoint

What could challenge this read

The sale could signal insider confidence issues, but size is too small to act on.

Key entities

  • company
    Crawford & Co

    Issuer of the shares sold.

  • person
    Bart Andrew John

    Executive Vice President and reporting officer.

Read at source← All news

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

CRD-A insider trading history →

Related articles

NOV 2
$CRD-AMedAI 8/10

Crawford & Company Reports 2026 Third Quarter Results

Crawford & Company (CRD-A, CRD-B) reported Q3 2026 revenues of $321.6M, down slightly from $322.2M in Q3 2025. Net income rose to $15.0M ($0.31 per share) from $12.4M ($0.25 per share). International operations drove improved performance, while U.S. segments saw declines. The CEO highlighted progress in cost management and client relationships, but expects fourth-quarter pressure from lower claims frequency.

saultstar.com6 min
AUG 3
$CRD-AMed

CRAWFORD & COMPANY REPORTS 2026 SECOND QUARTER RESULTS

CRAWFORD & CO (CRD-A) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Crawford & Company® 5335 Triangle Parkway Peachtree Corners, GA 30092 FOR IMMEDIATE RELEASE CRAWFORD & COMPANY REPORTS 2026 SECOND QUARTER RESULTS Strong Earnings Growth Driven by International Operations and Broadspire Quarterly Dividend Increases to $0.08 per Share

SEC EDGAR 8-K6 min
NOV 3
$ASPEMedAI 8/10

ARCH Venture Fund X, L.P. (CRANDELL KEITH, Burow Kristina) purchased $18.0M of ASPE (indirect holdings)

ARCH Venture Fund X, L.P. purchased 1,200,000 indirectly-held shares of Aspen Neuroscience, Inc. (ASPE) at $15.00 ($18.00M total) on 2026-11-02. Filed jointly with ARCH Venture Fund X Overage, L.P. (10% owner), ARCH Venture Partners X, L.P. (10% owner), ARCH Venture Partners X Overage, L.P. (10% owner), ARCH Venture Partners X, LLC (10% owner), CRANDELL KEITH (10% owner), Burow Kristina (10% owner), GILLIS STEVEN (10% owner) and NELSEN ROBERT (10% owner).

SEC EDGAR1 min
NOV 3
$ASPELow

ARCH Venture Fund X, L.P. (CRANDELL KEITH, Burow Kristina) purchased $2.0M of ASPE

ARCH Venture Fund X, L.P. purchased 133,333 shares of Aspen Neuroscience, Inc. (ASPE) at $15.00 ($2.00M total) across 2 trades on 2026-11-02. Filed jointly with ARCH Venture Fund X Overage, L.P. (10% owner), ARCH Venture Partners X, L.P. (10% owner), ARCH Venture Partners X Overage, L.P. (10% owner), ARCH Venture Partners X, LLC (10% owner), CRANDELL KEITH (10% owner), Burow Kristina (10% owner), GILLIS STEVEN (10% owner) and NELSEN ROBERT (10% owner).

SEC EDGAR1 min